# Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services, Bedford, NH – FDA Inspections

Source: https://www.keypedia.com/companies/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/a2a924d8-594c-4f2a-a998-5cbd4c06c983

> Inspection records and compliance data for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services in Bedford, New Hampshire. 9 FDA inspections on record (1 OAI), 3 Form 483s, last inspected June 10, 2026.

---

## Details

- Name: Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
- FEI Number: 3008546445
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 25 Commerce Dr
- City: Bedford
- State: New Hampshire
- Zip Code: 03110
- Country Name: United States
- Address: 25 Commerce Dr, Bedford, New Hampshire 03110, United States
- Country: United States

## Related Documents

- [483 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2026-06-10](https://www.keypedia.com/records/483/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/23fc9ad7-0523-4219-84ea-91277d02915d) — source: FDA, date: June 10, 2026
- FDA Inspection 1321518 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2026-06-10 — source: FDA, date: June 10, 2026
- [FDA Inspection 1321518 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2026-06-10](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/98be2869-e2d8-4d6d-8f31-f8b092a80149) — source: FDA, date: June 10, 2026
- [FDA Inspection 1239754 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2024-05-24](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/66bf6291-43c6-4007-aa3a-035315260b2e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2024
- FDA Inspection 1239754 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2024-05-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2024
- [483 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2023-09-27](https://www.keypedia.com/records/483/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/75c9f173-aa20-48af-801d-0567bd3f361b) — source: FDA, date: September 27, 2023
- [FDA Inspection 1218916 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2023-09-27](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/30671712-4711-4ae1-ac69-3a9a86a3c601) — classification: Official Action Indicated (OAI), source: FDA, date: September 27, 2023
- [483 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2021-04-15](https://www.keypedia.com/records/483/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/abff9fe5-5b8a-4081-8e5f-ca3fbaf38379) — source: FDA, date: April 15, 2021
- [483 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2020-11-05](https://www.keypedia.com/records/483/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/c96df70e-fb11-4e22-b6de-43a29e472416) — source: FDA, date: November 5, 2020
- [EIR - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2018-12-07](https://www.keypedia.com/records/eir/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/35bdd5a0-2438-4108-85fb-91d7aa287280) — source: FDA, date: December 7, 2018
- [483 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2018-12-07](https://www.keypedia.com/records/483/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/94fbf236-bfa7-48b8-963a-791efec4a0d9) — source: FDA, date: December 7, 2018
- [FDA Inspection 1074079 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2018-12-07](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/7c538adf-a0b1-4e0a-b885-7258322245ed) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2018
- FDA Inspection 1003136 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2017-02-15 — classification: No Action Indicated (NAI), source: FDA, date: February 15, 2017
- [FDA Inspection 1002975 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2017-02-15](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/7a8bda05-f6fb-4847-9c01-4422c91d436c) — classification: No Action Indicated (NAI), source: FDA, date: February 15, 2017
- [EIR - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2015-04-24](https://www.keypedia.com/records/eir/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/622bf5c4-e5eb-495f-b58f-526432114346) — source: FDA, date: April 24, 2015
- [FDA Inspection 925848 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2015-04-24](https://www.keypedia.com/records/fda_inspections/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/fa6b0351-f7a7-4729-bead-18279f848829) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 24, 2015
- FDA Inspection 901806 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2014-10-30 — classification: No Action Indicated (NAI), source: FDA, date: October 30, 2014
- [483 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - 2014-01-29](https://www.keypedia.com/records/483/lyophilization-services-of-new-england-inc-lsne-dba-pci-pharma-services/ea44ca0c-3122-4c5f-99ca-2a21474a70b0) — source: FDA, date: January 29, 2014

## Related Companies

- [Quagen Pharma, LLC](https://www.keypedia.com/companies/quagen-pharma-llc/cd9437ab-54e0-430e-a568-3835f717bdf1)
- [Lupin Limited](https://www.keypedia.com/companies/lupin-limited/218ee27f-639e-4fc4-995c-345bc58c3548)
- [Beauty Manufacturing Solutions Corp.](https://www.keypedia.com/companies/beauty-manufacturing-solutions-corp/08a59977-bbec-43d4-a6cd-f4ee0d6ca7aa)
- [Custom Research Labs Inc](https://www.keypedia.com/companies/custom-research-labs-inc/9b06cc46-d665-4363-bc5e-ab6cf9dfce31)
- [Delpharm Dijon](https://www.keypedia.com/companies/delpharm-dijon/8f766752-64b7-4166-b421-2fbe7803560d)
- [Packaging On Demand, Inc.](https://www.keypedia.com/companies/packaging-on-demand-inc/5bdb7fe3-4144-411f-9267-3fbc3f555c24)
- [LNK International, Inc.](https://www.keypedia.com/companies/lnk-international-inc/69c2d233-3b10-4e6e-8b0d-c9ac1a38d4c4)
- [Identipak Inc](https://www.keypedia.com/companies/identipak-inc/0472b825-0790-42d3-b71a-590233132990)
- [Northwest Cosmetic Laboratories LLC (DBA Elevation Labs Idaho)](https://www.keypedia.com/companies/northwest-cosmetic-laboratories-llc-dba-elevation-labs-idaho/e2c4448c-2912-46de-a068-d213f6cf5265)
- [Fareva Morton Grove](https://www.keypedia.com/companies/fareva-morton-grove/baf4391f-2077-4c00-8277-7fab233b2088)

## Related Officers

- [Cameron E. Moore](https://www.keypedia.com/people/cameron-e-moore/5a879539-24b7-4c54-99e4-b8e31f18ec9b)
- [investigator](https://www.keypedia.com/people/stacey-s-degarmo/f0dea08e-f65f-4664-9614-66f1997a95dc)
- [Arizona Market President](https://www.keypedia.com/people/john-p-mistler/7b2d423d-46cc-48bd-aa5a-4ae794888060)
- [company_representative](https://www.keypedia.com/people/jay-bonewit/2f0547e0-5cf4-4019-a01f-e40d8e573822)
- [Senior Consumer Safety Officer - Pharmaceutical Quality](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
